|
|
|
 |
     |
 |
|
|
|
|
|
|||
|
|
Traconol Plus
Traconol™ is made from a hybrid grape seed which exhibits antioxidant activity triple that found in other grape seed extracts. Made entirely in the U.S., the OPC (oligomeric proanthocyanidins) content of Traconol™ accounts for 95 percent of the product. Traconol™ inhibits the release and synthesis of compounds that promote infiammation and allergies. Traconol™ increases intracellular vitamin C levels 20 times and vitamin E levels 50 times. In 1950, Dr. Jacques Masquelier discovered proanthocyanidins, commonly called “OPCs”. He gave the name “pycnogenol” to this polyphenol chemical group, the fiavan-3-ols. In 1985, using grape seed extract, Dr. Masquelier discovered that OPCs possessed an intense free radical scavenging effect (FRSE). Free radicals – electrically charged molecules that can destroy normal molecules – cause oxidative damage to cells and tissues. Free radical damage plays a large role in the degenerative diseases associated with aging, cellular mutation which underlies cancerous processes, and other major diseases. Some of the therapeutical indications cited in the patent papers are: atherosclerosis, Alzheimer disease, cerebral hemorrhage, limits tumor growth, pre-cancer, and collagen diseases such as multiple sclerosis. The paper goes on to state that the radical scavenger effect, “...does not overcome aging, which is a biological process programmed in the genes, but it may prevent, attenuate or inhibit different harmful effects of aging caused by an excess of free radicals.” The patent (U.S. Patent No. 4,698,360) description which is dated October 6, 1987, also noted that in 30 years of use, there was not one instance of toxicity from OPCs. Traconol™ is water soluble so it is highly bioavailable. Within minutes, it is absorbed and on its way to the tissues. It remains in the body and collagen for three days. It inhibits enzymes which cause infiammation and break down collagen, the main protein in skin and connective tissue. Masquelier and other researchers found that OPCs can actually regenerate damaged collagen and repair some of the damage to wrinkled skin. OPCs can help restore capillary integrity and improve circulation. They have the ability to return fiexibility to skin, joints, arteries, capillaries and other body tissues. OPCs are one of the few biofiavonoids with the ability to cross the blood-brain barrier thus enabling them to protect the brain, spinal cord, and central nervous system from oxidation. Q: Who would benefit from using Traconol™? A: Everyone because free radical damage is cumulative and for the most part, undetectable and unnoticed until its result – disease – strikes. Antioxidants are the only known weapon against free radical damage. Of the over 2,000 biofiavonoids, OPCs are the most powerful scavengers of free radicals. The ability to cross the blood-brain barrier is especially important to protect the brain, spinal cord and central nervous system from such insults as stroke and Alzheimer’s disease. The ability to restore fiexibility to arteries and capillaries is important in the fight against heart and other cardiovascular diseases. With increased lifespan, the fact that OPCs can repair some of the damage to wrinkled skin is a bonus. Q: How much Traconol™ should I take? A: Approximately 1 mg per pound of body weight for 7–10 days to reach saturation level. Then reduce daily intake by half to replace the amounts excreted in the urine and through perspiration. Q: What is the source of the raw materials in Traconol™? A: Most grape seed extracts come from the grape seeds of relatively small Italian wineries. Manufacturers are forced to use whatever seeds are available. In developing Traconol™, research determined that the seeds and skins of one particular red grape hybrid possessed the highest antioxidant activity. The grape seeds and skins used to produce Traconol™ are supplied by an American firm which is one of the two largest wine producers in the world. Q: How pure is Traconol™? A: OPC accounts for 95% of Traconol™ (the other 5% is gallic acid and the other red wine antioxidants) and the product has a procyanidolic value (the amount of active OPC) of at least 100. It contains no methyl chloride, a toxic substance which is often seen as a by-product of the extraction process. Q: Are OPCs toxic? A: No. The patent papers dated October 6, 1987 stated that in 30 years of being used in therapeutical treatment, OPCs “...have never given rise to any intoxication whatever.” Q: Is there any other research being done? A: The ongoing research on Traconol™ being done at the University of California, Davis is very exciting. Current projects include determining which polyphenolic phytochemicals are most abundant in Traconol™ and how much can be found in human plasma after taking it; determining grape OPCs activity as a biological antioxidant; and determining the inhibition of LDL oxidation compared to a leading OPC product currently on the market. LDL oxidation plays a major role in heart disease. It is hoped that the research will establish that LDL oxidation is significantly inhibited by Traconol™. Q: Is Traconol™ the same as Pycnogenol®? A: No. “Pycnogenol” was the name Dr. Jacques Masqualier first gave to the class of bioflavonoid, fiavan-3-ols, to which proanthocyanidins (OPCs) belong. The name has since been trademarked by Horphag Overseas, Ltd. for OPC extracted from pine bark. Traconol™ is a trademark of Traco Labs for OPC extracted from a hybrid grape seed found to exhibit higher levels of antioxidant properties than those found in other grape seed extracts. Q: Are there other differences between the OPCs in Traconol™ and OPCs from pine bark? A: The OPC content in Traconol™ is a minimum of 100; other grape seed extracts range from 92-95; pine bark extract is around 85. Traconol™ also contains powerful gallic acid and other red wine antioxidants that some research indicates may reduce the risk of cardiovascular disease. Ingredients: Extract of grape seeds, citrus biofiavonoids, gelatin, glycerin, water, cellulose, magnesium stearate. Suggested use: Approximately 1 mg per pound of body weight for 7–10 days to reach body tissue saturation level. Then reduce daily intake by half for maintenance. Package size: 60 - 60 milligram caps
|
|
|
|||
|
|
|
|
|
|
Home | Books & Tapes | Nutrition Notebook | Our Privacy Policy | Contacts Springboard products which are foods and/or foods for
special dietary use, are not offered for the Copyright © 1998-2007 Springboard All rights reserved.
WebSite Designed and Managed by
|
